ALKSAlkermes plc

$5B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$187M+4.7% YoY

Gross Profit

$134M72.0% margin

Operating Income

-$46M-24.4% margin

Net Income

-$46M-24.4% margin

EPS (Diluted)

$-0.48

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$516M

Total Liabilities

$103M

Stockholders' Equity

$413M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$178M	+4.7%
Gross Profit	$134M	$129M	+4.4%
Operating Income	-$46M	-$43M	-6.0%
Net Income	-$46M	-$40M	-14.9%

ALKS FY 2010 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena